IQ-AI imaging technology gets vote of confidence in US study
(Alliance News) - IQ-AI Ltd unit Imaging Biometrics on Tuesday said a study concluded its imaging technology was successful in identifying tumours.
Read moreThu, 09th Jan 2020 09:49
(Alliance News) - IQ-AI Ltd unit Imaging Biometrics on Tuesday said a study concluded its imaging technology was successful in identifying tumours.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
Read moreIQ-AI Ltd - Jersey-based medical services firm - Says phase one clinical trial for oral gallium maltolate is open for enrolment. Patient recruitment in the trial is underway and potential volunteers that meet the inclusion criteria have already been identified, it notes. Phase one dose escalation study is designed to determine the optimal dose of GaM that can be administered safely. It is the first-in-human clinical trial for an oral form of GaM to be used in patients with high-grade brain tumours, it adds.
Read moreTRADING UPDATES: Beximco profit rises; Tremor buoyant as sales rise
Read moreTRADING UPDATES: Hunting hurt by Ida; React revenue short of consensus
Read moreTRADING UPDATES: Marlowe buys; Galliford snaps up nmcn's Water unit
Read moreTRADING UPDATES: Clinigen signs Copiktra deal; Alien "really pleased"
Read moreIN BRIEF: IQ-AI sells several licenses of Imaging Biometrics software
Read moreTRADING UPDATES: Argo gets GBP18 million loan; Genedrive fundraises
Read moreEXECUTIVE CHANGES: 600 Group rejigs board; Thor Mining chair resigns
Read moreTRADING UPDATES: Trifast buys in US; Eckoh trading meets expectations
Read moreIN BRIEF: IQ-AI interim loss narrows as sales regain lost momentum
Read moreEXECUTIVE CHANGES: Lloyds Banking appoints BT Digital Officer to board
Read moreSMALL-CAP WINNERS & LOSERS: Robert Walters boosts 2021 profit outlook
Read moreIQ-AI's medical imaging T1+C software granted a US patent
Read more